Acadia Healthcare Company, Inc.
ACHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 3.03 | 0.65 | -0.22 |
| FCF Yield | -15.43% | 0.54% | 1.14% | 2.41% |
| EV / EBITDA | 9.28 | 44.86 | 15.69 | 15.00 |
| Quality | ||||
| ROIC | 7.37% | 6.91% | 7.53% | 7.10% |
| Gross Margin | 22.57% | 23.31% | 96.16% | 96.08% |
| Cash Conversion Ratio | 0.49 | -29.52 | 1.36 | 1.91 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.51% | 8.16% | 7.69% | 4.84% |
| Free Cash Flow Growth | -1,567.51% | -54.74% | -34.89% | -70.68% |
| Safety | ||||
| Net Debt / EBITDA | 3.31 | 7.46 | 2.55 | 3.27 |
| Interest Coverage | 4.49 | 6.17 | 6.70 | 5.38 |
| Efficiency | ||||
| Inventory Turnover | 431.90 | 423.80 | 19.70 | 18.95 |
| Cash Conversion Cycle | 14.90 | 29.02 | -313.48 | -329.41 |